Edesa Biotech to Participate in Guggenheim's 3rd Annual Healthcare Innovation Conference

8-K filing — Edesa Biotech, Inc. (EDSA)

Filed: 2026-10-23 AccNo: 0001171843-26-006794 Size: 183 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Edesa Biotech Receives FDA Clearance For Its Investigational New Drug Application For Its Phase 2 Clinical Trial Of EB06 In Vitiligo

Edesa Biotech shares are trading lower after the company announced the pricing of its $25 million proposed public offering of 3,870,500 shares and warrants at a $5.50 combined price.

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers Circle8 Group (NASDAQ:CIRC) shares increased by 18.2% to $0.77 during Thursday's pre-market session. The company's market cap stands at $60.1 million. The company's, Q2 earnings came out yesterday.

Reported Earlier, Edesa Biotech Prices $25.0M Public Offering Of 3,870,500 Common Shares Plus Warrants At $5.50 Combined Price

Edesa Biotech Stock Sinks After Fresh Capital Raise

Edesa Biotech Stock falls in premarket trading as investors weigh a $25 million offering, new warrants and potential dilution.